Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Return on Capital Employed (2016 - 2022)

Historic Return on Capital Employed for Aptevo Therapeutics (APVO) over the last 7 years, with Q4 2022 value amounting to 1.18%.

  • Aptevo Therapeutics' Return on Capital Employed fell 3400.0% to 1.18% in Q4 2022 from the same period last year, while for Dec 2022 it was 1.18%, marking a year-over-year decrease of 3400.0%. This contributed to the annual value of 0.78% for FY2022, which is 2700.0% up from last year.
  • According to the latest figures from Q4 2022, Aptevo Therapeutics' Return on Capital Employed is 1.18%, which was down 3400.0% from 0.91% recorded in Q3 2022.
  • Aptevo Therapeutics' Return on Capital Employed's 5-year high stood at 0.61% during Q1 2018, with a 5-year trough of 2.74% in Q2 2020.
  • For the 5-year period, Aptevo Therapeutics' Return on Capital Employed averaged around 1.11%, with its median value being 0.85% (2019).
  • Per our database at Business Quant, Aptevo Therapeutics' Return on Capital Employed tumbled by -18800bps in 2020 and then surged by 20800bps in 2021.
  • Aptevo Therapeutics' Return on Capital Employed (Quarter) stood at 0.8% in 2018, then tumbled by -204bps to 2.42% in 2019, then skyrocketed by 61bps to 0.95% in 2020, then grew by 12bps to 0.84% in 2021, then crashed by -41bps to 1.18% in 2022.
  • Its Return on Capital Employed was 1.18% in Q4 2022, compared to 0.91% in Q3 2022 and 0.63% in Q2 2022.